首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Synthesis and Evaluation of 1-ArylsuIfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors~(1-4))V.A Series of New Derivatives Containing a Spiro[imidazo[1,2-a]pyrazine-2(3H),4'-piperidin]-5(1H)-one Scaffold
【24h】

Synthesis and Evaluation of 1-ArylsuIfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors~(1-4))V.A Series of New Derivatives Containing a Spiro[imidazo[1,2-a]pyrazine-2(3H),4'-piperidin]-5(1H)-one Scaffold

机译:1-芳基磺酰基-3-哌嗪酮衍生物作为Xa因子抑制剂的合成和评价〜(1-4))VA系列含螺并[咪唑并[1,2-a]吡嗪-2(3H),4'-的新衍生物哌啶] -5(1H)-一种支架

获取原文
获取原文并翻译 | 示例
           

摘要

We have already reported unique compounds containing a N,O-spiro acetal structure as an orally active factor Xa(FXa)inhibitor.This time,we described a N,N-spiro acetal structure as an analogue of the N,O-spiro acetal structure for an orally active FXa inhibitor.The synthesis of these analogues could be achieved in a similar fashion to the N,O-spiro acetal synthesis.Consequently,FXa inhibitory activity was increased and more active compounds could be found(M58163:IC_(50)=0.61 nM,M58169:IC_(50)=0.58 nM).Additionally,the absolute configuration could be determined by X-ray crystallography analysis(M58169:(R)-config.).
机译:我们已经报道了含有N,O-螺缩醛结构作为口服活性因子Xa(FXa)抑制剂的独特化合物。这一次,我们将N,N-螺缩醛结构描述为N,O-螺缩醛的类似物。这些类似物的合成可以通过与N,O-螺缩醛合成相似的方式完成。因此,FXa抑制活性增加,并且发现了更多的活性化合物(M58163:IC_(50 )= 0.61 nM,M58169:IC_(50)= 0.58 nM)。此外,可以通过X射线晶体学分析(M58169:(R)-config。)确定绝对构型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号